Is Viatris (VTRS) Pricing Reflect Its Recent Multi-Year Share Price Recovery [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
If you are wondering whether Viatris might still offer value at its current share price, this article walks through what the numbers are really saying about the stock. The shares recently closed at US$13.21, with returns of 2.7% over 7 days, 7.9% over 30 days, 6.0% year to date, 23.9% over 1 year and 27.5% over 3 years, while the 5 year return sits at a 4.9% decline. Recent news coverage has focused on Viatris as a large U.S. listed pharmaceuticals and biotech company. This keeps investor attention on how its portfolio, cash flows and balance sheet support the current share price. This context helps frame whether the recent share price moves are aligned with the underlying business profile or driven more by changing risk sentiment. On Simply Wall St's 6 point valuation check, Viatris scores 5 out of 6 . This sets up a closer look at how different valuation methods compare and hints at an even richer way of thinking about value that we will come to at the end of the article. F
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Davis Opportunity Fund Annual Review 2026 [Seeking Alpha]Seeking Alpha
- Viatris (VTRS) Valuation Check After First International Inpefa Heart Failure Launch [Yahoo! Finance]Yahoo! Finance
- Viatris Earnings Preview: What to Expect [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Sell VTRS and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 1/2/26 - Form 4
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- VTRS's page on the SEC website